Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity

[1]  C. Bien,et al.  Autoimmune epilepsies. , 2011, Current opinion in neurology.

[2]  K. Chu,et al.  VGKC-complex/LGI1-antibody encephalitis: Clinical manifestations and response to immunotherapy , 2013, Journal of Neuroimmunology.

[3]  M. Jorge Cardoso,et al.  Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. , 2013, Brain : a journal of neurology.

[4]  C. Elger,et al.  Neuropsychological course of voltage‐gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis , 2013, European journal of neurology.

[5]  J. Schott,et al.  Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  C. Klein,et al.  Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. , 2013, JAMA neurology.

[7]  A. Vincent,et al.  Morvan syndrome: Clinical and serological observations in 29 cases , 2012, Annals of neurology.

[8]  J. Britton,et al.  Autoimmune epilepsy: clinical characteristics and response to immunotherapy. , 2012, Archives of neurology.

[9]  J. Schott,et al.  Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis , 2011, Annals of neurology.

[10]  I. Scheffer,et al.  Autoantibodies and epilepsy , 2011, Epilepsia.

[11]  A. Ebner,et al.  Limbic encephalitis in children and adolescents , 2010, Archives of Disease in Childhood.

[12]  R. Balice-Gordon,et al.  Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series , 2010, The Lancet Neurology.

[13]  A. Vincent,et al.  Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia , 2010, Brain : a journal of neurology.

[14]  A. Larner,et al.  An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  H. Urbach,et al.  Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis , 2010, Annals of neurology.

[16]  S. Cha,et al.  Adult‐onset drug‐refractory seizure disorder associated with anti–voltage‐gated potassium‐channel antibody , 2010, Epilepsia.

[17]  H. Willison,et al.  Voltage-gated Potassium Channel-associated Limbic Encephalitis in the West of Scotland: Case Reports and Literature Review , 2009, Scottish medical journal.

[18]  C. Elger,et al.  NeuroCog FX: Computerized screening of cognitive functions in patients with epilepsy , 2009, Epilepsy & Behavior.

[19]  S. Smith,et al.  IMMUNOTHERAPY-RESPONSIVE SEIZURE-LIKE EPISODES WITH POTASSIUM CHANNEL ANTIBODIES , 2008, Neurology.

[20]  C. Elger,et al.  Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy , 2007, Neurology.

[21]  J. Palace,et al.  Serum antibodies in epilepsy and seizure-associated disorders , 2005, Neurology.

[22]  H. Urbach,et al.  Imaging of the epilepsies , 2005, European Radiology.

[23]  B. Boeve,et al.  Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody , 2004, Neurology.

[24]  M. Rossor,et al.  Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. , 2004, Brain : a journal of neurology.

[25]  A. Schulze-Bonhage,et al.  Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy , 2000, Neurology.

[26]  H. Reiber.  Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases , 1998, Multiple sclerosis.

[27]  H. Reiber,et al.  The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis , 1998, Multiple sclerosis.

[28]  O. Pongs,et al.  Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia , 1997, Annals of neurology.

[29]  J. G. van Dijk,et al.  Acquired neuromyotonia: Evidence for autoantibodies directed against K+ channels of peripheral nerves , 1995, Annals of neurology.

[30]  T. Babb,et al.  The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. , 1995, Brain : a journal of neurology.

[31]  J. Corsellis,et al.  "Limbic encephalitis" and its association with carcinoma. , 1968, Brain : a journal of neurology.

[32]  J. Brierley,et al.  SUBACUTE ENCEPHALITIS OF LATER ADULT LIFE. MAINLY AFFECTING THE LIMBIC AREAS , 1960 .

[33]  E. Langhoff,et al.  Relative immunosuppressive potency of various corticosteroids measured in vitro , 2004, European Journal of Clinical Pharmacology.

[34]  Jerome Engel,et al.  Outcome with respect to epileptic seizures. , 1993 .

[35]  Jerome Engel,et al.  Surgical treatment of the epilepsies , 1993 .